Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ductal Carcinoma in Situ - Category
Interventions: DRUG: (18F)FES|DRUG: Gadobenate dimeglumine
Sponsor: University of Wisconsin, Madison
Collaborators: National Cancer Institute (NCI)|National Center for Advancing Translational Sciences (NCATS)